Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
jeudi, octobre 15
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Novavax Inc
NVAX
NASDAQ
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$12.63
-0.01
-0.08%
Dern. MÀJ: Oct 15, 9:43 AM
$12.45
-0.19
-1.5%
Get Report
Aperçu
Actualités
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Actionnariat
Comparer
Options
Rapport sur les stocks
Privacy Manager
Novavax Financials
Novavax (NVAX) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Novavax Raises FY2026 Sales Guidance from $230.000M-$270.000M to $235.000M-$275.000M vs $389.234M Est
Novavax (NASDAQ:NVAX) raises FY2026 sales outlook from $230.000 million-$270.000 million to $235.000 million-$275.000 million vs $389.234 million estimate.
Benzinga Newsdesk
PRO
Novavax Q2 EPS $(0.32) Beats $(0.37) Estimate, Sales $56.698M Beat $52.513M Estimate
Benzinga Newsdesk
Earnings Scheduled For May 6, 2026
Benzinga Insights
Why Novavax Stock Is Trading Higher On Wednesday?
Novavax shares rise after Q1 revenue beat; partnerships, credit facility, and technical levels shape outlook amid shift to net loss.
Vandana Singh
PRO
Novavax Affirms FY2026 Sales Guidance of $230.000M-$270.000M vs $393.277M Est
Novavax (NASDAQ:NVAX) affirms FY2026 sales outlook from $230.000 million-$270.000 million to $230.000 million-$270.000 million vs $393.277 million estimate.
Benzinga Newsdesk
PRO
Novavax Q1 EPS $(0.06), Sales $139.514M Beat $78.323M Estimate
Novavax (NASDAQ:NVAX) reported quarterly losses of $(0.06) per share. This is a 102.05 percent decrease over earnings of $2.93 per share from the same period last year. The company reported quarterly sales of $139.514
Benzinga Newsdesk
